Enhanced HIV-1 Vaccines and Methods for Their Use
Patent Cooperation Treaty
PCT/US2004/09617
Filed on 2004-03-29
PCT/US2004/09617
Filed on 2004-03-29
Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA)
Ireland
98948429.0
Filed on 1998-09-22
98948429.0
Filed on 1998-09-22
Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA)
Belgium
98948429.0
Filed on 1998-09-22
98948429.0
Filed on 1998-09-22
Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA)
Switzerland
98948429.0
Filed on 1998-09-22
98948429.0
Filed on 1998-09-22
Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA)
Spain
98948429.0
Filed on 1998-09-22
98948429.0
Filed on 1998-09-22
Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA)
Italy
98948429.0
Filed on 1998-09-22
98948429.0
Filed on 1998-09-22
Agonist and Antagonist Petide of Carcinoembryonic Antigen (CEA)
United Kingdom
98948429.0
Filed on 1998-09-22
98948429.0
Filed on 1998-09-22
Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA)
France
98948429.0
Filed on 1998-09-22
98948429.0
Filed on 1998-09-22
Agonist and Antagonist Peptides of Carcinoembryonic Antigen (CEA)
Germany
98948429.0
Filed on 2000-04-07
98948429.0
Filed on 2000-04-07
Broadly Cross-Reactive Neutralizing Antibodies Against Human Immunodeficiency Virus selected By ENV-CD4-CO-Receptor Complexes
India
1073/CHEN/2004
Filed on 2002-10-16
1073/CHEN/2004
Filed on 2002-10-16